GM1型2型神经节苷脂病一例模拟Zellweger综合征

N. R. Ganampet, P. J. Charpuria, P. C. Chemudupati Parven, Shresta Mary K, Dirgha Patel, Smaran Kasireddy
{"title":"GM1型2型神经节苷脂病一例模拟Zellweger综合征","authors":"N. R. Ganampet, P. J. Charpuria, P. C. Chemudupati Parven, Shresta Mary K, Dirgha Patel, Smaran Kasireddy","doi":"10.34257/gjmravol23is3pg21","DOIUrl":null,"url":null,"abstract":"Juvenile GM1-gangliosidosis, also known as type II or juvenile GM1-gangliosidosis, is an autosomal recessive lysosomal storage disorder that clinically differs from infantile GM1-gangliosidosis in the absence of the characteristic cherry-red patch and hepatosplenomegaly. The disease is characterized by mild skeletal abnormalities and slowly progressing neurodegeneration. Due to the late age of onset and unusual presentation, diagnostic confusion with other ataxic and purely neurological disorders is common. There are currently 3–4 recognized types of GM1-gangliosidosis, with type I being the most prevalent phenotype with an average onset age of 6 months. Several subtypes of GM1-gangliosidosis are caused by mutations in the GLB1 gene, but the location and type of deleterious mutations have a direct impact on the severity of the disease and the age at which it manifests. A fully immunized 8-month-old male presented to our hospital with complaints of mild feeding difficulty, periorbital edema, and fever. Facial dysmorphism, hypotonia, delayed development, and hepatomegaly were observed in the patient. As there is currently no effective treatment for GM1 gangliosidosis, the carrier of the disease receives only symptomatic and palliative care. Given that genetic counseling is now the only means of preventing the disease, early diagnosis is crucial.","PeriodicalId":93101,"journal":{"name":"Global journal of medical research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Case of GM 1 Gangliosidosis Type 2 Mimicking Zellweger Syndrome\",\"authors\":\"N. R. Ganampet, P. J. Charpuria, P. C. Chemudupati Parven, Shresta Mary K, Dirgha Patel, Smaran Kasireddy\",\"doi\":\"10.34257/gjmravol23is3pg21\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Juvenile GM1-gangliosidosis, also known as type II or juvenile GM1-gangliosidosis, is an autosomal recessive lysosomal storage disorder that clinically differs from infantile GM1-gangliosidosis in the absence of the characteristic cherry-red patch and hepatosplenomegaly. The disease is characterized by mild skeletal abnormalities and slowly progressing neurodegeneration. Due to the late age of onset and unusual presentation, diagnostic confusion with other ataxic and purely neurological disorders is common. There are currently 3–4 recognized types of GM1-gangliosidosis, with type I being the most prevalent phenotype with an average onset age of 6 months. Several subtypes of GM1-gangliosidosis are caused by mutations in the GLB1 gene, but the location and type of deleterious mutations have a direct impact on the severity of the disease and the age at which it manifests. A fully immunized 8-month-old male presented to our hospital with complaints of mild feeding difficulty, periorbital edema, and fever. Facial dysmorphism, hypotonia, delayed development, and hepatomegaly were observed in the patient. As there is currently no effective treatment for GM1 gangliosidosis, the carrier of the disease receives only symptomatic and palliative care. Given that genetic counseling is now the only means of preventing the disease, early diagnosis is crucial.\",\"PeriodicalId\":93101,\"journal\":{\"name\":\"Global journal of medical research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global journal of medical research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34257/gjmravol23is3pg21\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global journal of medical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34257/gjmravol23is3pg21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

幼年型gm1神经节脂质沉积症,也称为II型或幼年型gm1神经节脂质沉积症,是一种常染色体隐性溶酶体贮积症,临床上与婴儿型gm1神经节脂质沉积症不同,没有特征性的樱桃红色斑块和肝脾肿大。这种疾病的特征是轻微的骨骼异常和缓慢进展的神经变性。由于发病年龄晚,表现不寻常,与其他共济失调和纯粹神经系统疾病的诊断混淆是常见的。目前公认的gm1神经节脂质病有3-4种类型,其中I型为最常见的表型,平均发病年龄为6个月。gm1神经节脂质沉积症的几种亚型是由GLB1基因突变引起的,但有害突变的位置和类型对疾病的严重程度和表现年龄有直接影响。一名8月龄男性患者,经全面免疫后,以轻度进食困难、眶周水肿及发热就诊。患者表现为面部畸形、肌张力低下、发育迟缓、肝肿大。由于目前没有针对GM1神经节脂质病的有效治疗方法,该疾病的携带者只能接受对症治疗和姑息治疗。鉴于遗传咨询是目前预防这种疾病的唯一手段,早期诊断至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A Case of GM 1 Gangliosidosis Type 2 Mimicking Zellweger Syndrome
Juvenile GM1-gangliosidosis, also known as type II or juvenile GM1-gangliosidosis, is an autosomal recessive lysosomal storage disorder that clinically differs from infantile GM1-gangliosidosis in the absence of the characteristic cherry-red patch and hepatosplenomegaly. The disease is characterized by mild skeletal abnormalities and slowly progressing neurodegeneration. Due to the late age of onset and unusual presentation, diagnostic confusion with other ataxic and purely neurological disorders is common. There are currently 3–4 recognized types of GM1-gangliosidosis, with type I being the most prevalent phenotype with an average onset age of 6 months. Several subtypes of GM1-gangliosidosis are caused by mutations in the GLB1 gene, but the location and type of deleterious mutations have a direct impact on the severity of the disease and the age at which it manifests. A fully immunized 8-month-old male presented to our hospital with complaints of mild feeding difficulty, periorbital edema, and fever. Facial dysmorphism, hypotonia, delayed development, and hepatomegaly were observed in the patient. As there is currently no effective treatment for GM1 gangliosidosis, the carrier of the disease receives only symptomatic and palliative care. Given that genetic counseling is now the only means of preventing the disease, early diagnosis is crucial.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Gender Determination by Measuring the Mandibular Ramus and Body of the Mandible: A Retrospective Radiographic Study Hepatitis C Virus Infected Human Megakaryocytes and Platelets: Intra-and Extracellular Evaluation Preferential Induction of Canonical IMD and Toll Innate Immune Receptors by Bacterial Challenges in Triatoma Pallidipennis Primed with Gram-Negative and Gram-Positive Bacteria, Respectively PPIB Unveiled: A Comprehensive Pan-Cancer Exploration Unraveling Immunological Signatures and Prognostic Implications Self-Reported Cardiovascular Risk Factors among Medical Students
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1